MEN I gene mutations in sporadic adrenal adenomas
✍ Scribed by K.-M. Schulte; M. Heinze; M. Mengel; D. Simon; S. Scheuring; K. Köhrer; H.-D. Röher
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 226 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To clarify the role of the MEN1 gene in the tumorigenesis of sporadic adrenocortical tumors, we performed a molecular study on 35 adrenocortical lesions including 6 hyperplasias, 19 adenomas and 10 carcinomas. Loss of heterozygosity (LOH) of the MEN1 gene was assessed by PCR using an intragenic (D11
The MEN1 gene on chromosome 11q13 is mutated in patients afflicted with multiple endocrine neoplasia syndrome type 1 (MEN1). These patients develop endocrine tumours of the pancreas, the parathyroid, and the anterior pituitary. In order to determine the role of MEN1 in sporadic pituitary adenomas, 6
## Abstract Inactivating mutations in __APC__ are thought to be early, initiating events in colorectal carcinogenesis. To gain insight into the relationship between diet and inactivating __APC__ mutations, we evaluated associations between dietary factors and the occurrence of these mutations in a
We examined the expression of matrilysin mRNA in sporadic and hereditary colorectal adenomas to clarify the role of matrilysin in tumorigenesis. Matrilysin mRNA was not detected in normal colorectal mucosa from patients with either sporadic or familial adenomas. Matrilysin mRNA expression in sporadi